Lymphangiomatosis Systemic [Lymphangiomatosis Systemica; Lymphangioma (Base Lymphangiomat-) + -O]

Lymphangiomatosis is a rare disease characterized by the appearance of multiple tumors of the lymphatic vessels, called lymphangiomas. Lymphangiomas can occur in a variety of organs and tissues, including the skin, lungs, liver, kidneys, brain, and others.

Symptoms of lymphangiomatosis may include enlargement of organs, pain in the area of ​​tumors, breathing problems, swelling, bleeding, and others. Treatment for lymphangiomatosis can be surgery or medication, but a combination of treatments is often required.

Lymphangiomatosis can have a variety of causes, including genetic factors, radiation exposure, infections, and other diseases. Diagnosis of lymphangiomatosis includes blood tests, ultrasound, computed tomography and other diagnostic methods.

The prognosis of lymphangiomatosis depends on the type of tumor, its size and location. In some cases, lymphangiomatoses can be cured completely, but in other cases they can lead to serious complications and even death.

Overall, lymphangiomatosis is a rare but serious disease that requires timely diagnosis and treatment.

Lymphangious lymphopathy is a tumor, malignant disease of the lymphatic vessels, which belong to the vascular bed. The disease is considered very rare. It accounts for no more than 0.3% of all oncological pathologies. In medical science it is characterized not only as a diagnosis, but also as a separate form of the disease. It is classified as a benign vascular neoplasm. Most adult patients and children over two years of age have lymphatic disorders. The disease is distinguished by clearly established signs, type of course, rate of development of symptoms, and consequences. With a timely diagnosis